K
KLOTHO NEUROSCIENCES, INC.
NASDAQ: KLTO (Klotho Neurosciences, Inc.)
Kemas kini terakhir: 5 jam lalu0.221
0.00 (1.33%)
| Penutupan Terdahulu | 0.218 |
| Buka | 0.216 |
| Jumlah Dagangan | 248,297 |
| Purata Dagangan (3B) | 692,075 |
| Modal Pasaran | 16,023,361 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -0.270 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 276.80% |
| Nisbah Semasa (MRQ) | 0.290 |
| Aliran Tunai Operasi (OCF TTM) | -4.48 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -1.95 M |
| Pulangan Atas Aset (ROA TTM) | -151.41% |
| Pulangan Atas Ekuiti (ROE TTM) | -1,544.44% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Klotho Neurosciences, Inc. | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.7 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | 0.0 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | -5.0 |
| Persekitaran Makro | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | -1.02 |
|
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 50.23% |
| % Dimiliki oleh Institusi | 2.60% |
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |